BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6137075)

  • 1. [The effect of anapriline on the thyroid function and lipid metabolism in ischemic heart disease in elderly patients].
    Gorbachev VV; Pristrom MS
    Ter Arkh; 1983; 55(5):53-6. PubMed ID: 6137075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Frequently used beta-blockers and circulating thyroid hormones].
    Custro N; Scafidi V; De Francisci MC
    Minerva Endocrinol; 1986; 11(3):185-9. PubMed ID: 2879217
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of anaprilin and a glucose-insulin-potassium mixture on carbohydrate and lipid metabolic indices in unstable stenocardia].
    Bashmakova NV
    Vrach Delo; 1982 Jun; (6):53-7. PubMed ID: 6126046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Bragina GI
    Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of disorders in carbohydrate, lipid metabolism and thyroid function in population of working 40--59 years old males].
    Serafin-Król M; Wagrowska H; Chotkowska E; Król J; Rywik S; Kuch J
    Przegl Lek; 1982; 39(5):371-4. PubMed ID: 7122921
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sympathetic-adrenal system in ischemic heart disease before and after obzidan treatment].
    Orlov VN; Chigrinova LS
    Klin Med (Mosk); 1981 Jun; 59(6):74-8. PubMed ID: 6116820
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with preparation LB-46 in various rhythm disorders and ischemic heart disease].
    De La Hoz Fabra J; Pérez Casar F; Carillo Kabana J
    Rev Esp Cardiol; 1970; 23(1):76-99. PubMed ID: 4393269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Echocardiographic study of left ventricular function in basic conditions and after drug administration].
    Colombo F; Pozzoli G; Castelli MR; Ravizza P; Dallosta V; Radice M; De Ambroggi L
    Boll Soc Ital Cardiol; 1980; 25(9):1103-7. PubMed ID: 6116497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thyroid hyperfunction in coronary atherosclerosis].
    Ionescu A; Sneer A; Marcu C; Priboi R
    Stud Cercet Endocrinol; 1971; 22(2):147-58. PubMed ID: 5566236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of beta receptor blockers on carbohydrate metabolism].
    Bretzke G
    Z Arztl Fortbild (Jena); 1981 Sep; 75(18):859-60. PubMed ID: 6125061
    [No Abstract]   [Full Text] [Related]  

  • 13. [Functional state of the cardiovascular system and lipid metabolism in elderly patients with ischemic heart disease].
    Korkushko OV; Bogatskaia LN; Kotko DN; Plachinda IuI; Novikova SN
    Vrach Delo; 1983 Jun; (6):22-7. PubMed ID: 6624021
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma lipids in men with coronary artery disease. Triglyceride-elevating effect of beta-blockaders].
    Faergeman O; Schläger J; Efsen F; Meinertz H
    Ugeskr Laeger; 1983 Mar; 145(13):978-9. PubMed ID: 6134366
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differentiated therapy of patients with chronic coronary insufficiency].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1969 Apr; 41(4):74-82. PubMed ID: 4191108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with the prolonged use of beta-adrenergic blocking agents in the ambulatory treatment of patients with ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1980; 52(8):99-103. PubMed ID: 6114576
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience in treatment of patients with ischemic heart disease by means of beta adrenergic blocking agents].
    Lebedev SV
    Klin Med (Mosk); 1977 May; 55(5):54-7. PubMed ID: 17769
    [No Abstract]   [Full Text] [Related]  

  • 20. [The dynamics of lipid peroxidation in patients with ischemic heart disease and hypertension during anaprilin treatment].
    Koryt'ko IN
    Vrach Delo; 1990 Apr; (4):43-5. PubMed ID: 2275164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.